Overview

Prevention of Early Asthma in Kids (PEAK)

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator:
Childhood Asthma Research and Education Network
Treatments:
Anti-Asthmatic Agents
Criteria
Asthmatic children from birth to 18 years. Emphasis is placed on infants and young children
through 5 years of age.